Table E4.
Characteristic | 1A | 2B | 3C | 4D | 5E | 6F | 7G | 8H | 9I | 10J |
---|---|---|---|---|---|---|---|---|---|---|
Cellular memory immunity | ||||||||||
Memory B-cell response | No | Yes | No | No | No | No | No | No | Yes | No |
Memory T-cell response∗ | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Antibody titers†‡ (cutoff/borderline/median) | ||||||||||
IgG (25.1/22.5/6.5 AU/mL) | 9.7‡ | 6.6‡ | 8.6‡ | 7.5‡ | 3.1 | 11.5‡ | 9.2‡ | 16.2‡ | 23.2† | 9.6‡ |
IgM (14.4/7.8/3.0 AU/mL) | 3.7‡ | 7.0‡ | 4.3‡ | 4.6‡ | 2.5 | 6.5‡ | 2.2 | 11.2† | 10.5† | 3.7‡ |
IgA (2.6/1.4/0.1 AU/mL) | 0 | 0 | 2.1† | 0 | 0 | 0 | 1.1‡ | 0.5‡ | 2.1† | 0.0 |
Symptoms | ||||||||||
Any symptoms Feb 20 to Jan 21 | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | No |
Time from symptoms to clinical visit§ | 0 | NA | 0 | NA | NA | 2 | 8 | 10 | 1 | NA |
Other factors | ||||||||||
Self-reported positive PCR test | No | No | No | No | No | No | No | No | Yes | No |
COVID-19 in household‖ | No | No | Yes | No | No | No | Yes | No | Yes | Yes |
Participant cohort identification numbers are renamed by 1 number and 1 letter that cannot be connected to original identification numbers. NA, Not applicable.
Positive in at least 1 T-cell assay.
Bordeline positive antibody titer.
Titer exceeding median antibody titer value in seronegative group.
Time in months between latest episode of reported symptoms and clinical visit.
Suspected or confirmed COVID-19 disease in household.